Dr. David R. Reinstadler, MD

Dr. Reinstadler practices at PIH Health Physicians in Whittier, California.

Dr. Reinstadler's NPI, 1225260862, was assigned on August 16, 2009. Dr. Reinstadler graduated from Keck School of Medicine of USC in 2008. Dr. Reinstadler holds California license A109185.

Dr. Reinstadler's primary practice is PIH Health Physicians, at 12522 E Lambert Rd, Whittier, CA 90606 in Los Angeles County. The practice phone is (562) 789-5420.

Dr. Reinstadler's primary practice is PIH Health Physicians in Whittier, California. Dr. Reinstadler is also affiliated with PIH Health Whittier Hospital. The medical group on file is PIH Health Physicians. Dmand AI also links Dr. Reinstadler to 1 more physician office and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Reinstadler practices, 3 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Reinstadler's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Reinstadler is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dr. Reinstadler is licensed in California.

Dmand AI lists acute sinusitis, chronic nasal allergies, chronic sinusitis, ear eustachian tube disorders, ear infection, endoscopic sinus surgery, hearing loss and impairment and larynx and vocal cord disease among the conditions Dr. Reinstadler treats.

CMS data shows 771 Medicare services from Dr. Reinstadler across 8 procedure codes in 2024, for 359 Medicare patients. Medicare paid $62,686 for them. Every service was in an office.

CMS counts 359 Medicare patients who saw Dr. Reinstadler in 2024. The largest group is 65 to 74, with 145 patients. 75% of them have high cholesterol, and 74% have high blood pressure. 16% are also on Medicaid. Their average risk score is 1.45, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Reinstadler's median patient age at 65, with 56% women.

In 2024, Dr. Reinstadler wrote 500 Medicare Part D claims for 289 patients. 96% of them were for generic drugs. CMS names the drug for 461 of them, across 14 drugs with 11 or more claims each, at $9,590 in total drug cost. In 2023, CMS named 477 claims across 13 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 79 out of 100 for Dr. Reinstadler for performance year 2024, reported as part of a group. Dr. Reinstadler accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Reinstadler as offering telehealth.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 3 papers to Dr. Reinstadler, published from 2012 to 2020. 2012 was the busiest year, with 2. Dr. Reinstadler's most frequent co-authors are Tamara Noelle Chambers, MD, Sanjeet Singh Dadwal, MD and Ellie G. Maghami, MD.

CMS Open Payments shows 1 general payment to Dr. Reinstadler from 1 drug or device company in 2018. Speaker and faculty fees make up the largest share, 100% of the total. Sanofi Pasteur Inc. paid the most, $25.

Dr. Reinstadler graduated from Keck School of Medicine of USC in 2008.

Dr. Reinstadler is in network with 8 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.